News
September 21, 2011:
BroadOak Partners advises Orion Genomics, LLC, a privately held biotechnology company developing epigenetic research tools and molecular diagnostic products, on the non-exclusive license of the Company’s MethylScreen technology for research use in QIAGEN’s EpiTect Methyl qPCR Array System reagent kits.
Download Press Release.
September 7, 2011:
BroadOak Partners has been retained to provide ongoing financial advisory services to Cenetron Diagnostics, Ltd. Cenetron Diagnostics is a central laboratory that supports global companies in Phase I to Phase IV clinical trials. The company offers a complete array of services including protocol review, technology consultation, laboratory testing, kit development and assembly, as well as clinical study data management.
March 10, 2011:
We are pleased to announce that Kyle Wilson has joined BroadOak Capital Partners. As a new Partner, Kyle will build on his 13 years of investment banking experience and continue to provide superior M&A and capital formation advice to life sciences companies. Prior to BroadOak, Kyle was a Principal at Canaccord Genuity where he led the tools and diagnostics team and completed over $1.4 billion in life sciences transactions. Kyle was also a Vice President at RBC Capital markets where he successfully executed over $700 million in transactions. Kyle holds a B.S. in Business Administration, a Juris Doctorate and M.B.A., all from the University of Oklahoma.
With the addition of Kyle’s expertise and experience, BroadOak is even better positioned to provide its life sciences clients with access to deep domain expertise combined with transactional excellence. We welcome Kyle to the firm.
September 7, 2010:
BroadOak Partners advises Selected Value Therapeutics I, LLC. on a securities purchase agreement with EntreMed Inc. (ENMD) and licensing of development and commercialization rights for ENMD-2076 in China.
July 20, 2010:
BroadOak Partners advises Cayman Chemical Company, Inc. on the replacement and expansion of its debt facilities and was lead investor for the mezzanine tranche.
June 15, 2010:
BroadOak Partners advises Albany Molecular Research, Inc., a leading contract manufacturer, on the acquisition of Hyaluron, Inc., a provider of cGMP manufacturing and sterile fill capabilities.
Download Press Release.
April 19, 2010:
BroadOak Partners advises Molecular Transfer, Inc., a leading producer of transfection and transformation reagents, on the acquisition of GlobalStem, Inc., a provider of high-quality standardized tools and reagents used in stem cell research.
Download Press Release.
December 11, 2009:
BroadOak Partners advises Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, on the sale of Xenogen Biosciences Corporation, a subsidiary which provides in-vivo preclinical CRO services, to Taconic Farms, Inc.
Download Press Release.
October 28, 2009:
BroadOak Partners advises Alpha Innotech Corp., a leading provider of imaging systems to the life sciences industry, on the sale of the Company to Cell Biosciences, Inc.
Download Press Release.
October 9, 2009:
BroadOak Partners advises Orion Genomics, LLC, a privately held biotechnology company developing epigenetic research tools and molecular diagnostic products for personalized medicine, on the discovery collaboration and license agreement to advance personalized diagnostics with Novartis AG.
Download Press Release.
August 31, 2009:
BroadOak Partners advises Clinical Data, Inc., a biotechnology company developing early and late stage therapeutics, on the sale of certain non-core assets to Intrexon Corporation.
Download Press Release.
August 3, 2009:
BroadOak Partners provides financial advice to Turner BioSystems, Inc., a provider of microplate and single tube reader instruments for the life science industry, on its sale to Promega Corp.
March 12, 2009:
BroadOak Partners advises Assay Designs, Inc., a provider of research product kits and reagents to the life science’s industry, on the sale of the Company to Enzo Biochem, Inc.
Download Press Release.
October 20, 2008:
BroadOak Partners advises Semrock Inc., a leading provider of optical filters in the life science market, on the sale of the Company to IDEX Corp. (NYSE: IEX).
Download Press Release.
September 3, 2008:
BroadOak Partners advises Alpha Innotech Corp. (APNO.OB) on the replacement and expansion of its debt facilities.
June 11, 2008:
BroadOak Partners advises Orion Genomics, LLC. on its licensing agreement with Johns Hopkins University over exclusive worldwide rights to the IGF2 gene for Colorectal Cancer Risk testing.
Download Press Release.
April 2, 2008:
BroadOak Partners advises PharmAthene, Inc. on its acquisition of Avecia Biologics Limited’s vaccines business.
Download Press Release.
June 28, 2007:
BroadOak Capital Partners advises Martek Biosciences Corp. on the sale of its fluorescent detection products business.
June 25, 2007:
BroadOak Partners granted membership to the NASD (NASD became FINRA on July 27, 2007).